indazoles has been researched along with gsk2292767 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amour, A; Baldwin, IR; Cooper, AW; Deakin, AM; Down, K; Felton, LM; Guntrip, SB; Hamblin, JN; Hardy, C; Harrison, ZA; Jones, KL; Jones, P; Keeling, SE; Le, J; Livia, S; Lucas, F; Lunniss, CJ; Parr, NJ; Robinson, E; Rowland, P; Smith, S; Thomas, DA; Vitulli, G; Washio, Y | 1 |
| Begg, M; Cahn, A; Clark, J; Edwards, CD; Ehtesham, F; Fernando, D; Gilbert, J; Hamblin, JN; Harrell, A; Hessel, EM; Hingle, MI; Mallett, D; Marotti, M; Morrell, J; Newman, CF; Pefani, E; Uddin, S; Vitulli, G; Wilson, R | 1 |
1 trial(s) available for indazoles and gsk2292767
| Article | Year |
|---|---|
Translation of Inhaled Drug Optimization Strategies into Clinical Pharmacokinetics and Pharmacodynamics Using GSK2292767A, a Novel Inhaled Phosphoinositide 3-Kinase
Topics: Administration, Inhalation; Adult; Animals; Bronchoalveolar Lavage; Eosinophilia; Female; Humans; Indazoles; Lung; Male; Mice; Middle Aged; Permeability; Phosphoinositide-3 Kinase Inhibitors; Safety; Solubility; Sputum; Sulfonamides; Translational Research, Biomedical | 2019 |
1 other study(ies) available for indazoles and gsk2292767
| Article | Year |
|---|---|
Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.
Topics: Administration, Inhalation; Animals; Asthma; Female; Humans; Indazoles; Indoles; Isoenzymes; Male; Microsomes; Molecular Docking Simulation; Ovalbumin; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Pneumonia; Pulmonary Disease, Chronic Obstructive; Rabbits; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Th2 Cells | 2015 |